Aprepitant bulk supplier for pharma manufacturers

Aprepitant 80 mg, 125 mg capsules Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 80 mg, 125 mg capsules

Reference Brands: Emend (US/EU)

Category: Oncology Cancer Care

Aprepitant is a prescription medicine used to prevent nausea and vomiting caused by chemotherapy.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Aprepitant? List it or send an offer →

Product Description:

Aprepitant blocks the neurokinin-1 receptor, where substance P acts. Chemotherapy-induced vomiting has two phases: an acute phase in the first day, driven largely by serotonin, and a delayed phase over the following days, driven by substance P. 5-HT3 antagonists control the first and do little for the second, which is why the addition of an NK1 antagonist changed the management of highly emetogenic chemotherapy.

It is used to prevent nausea and vomiting from cisplatin-based and other highly emetogenic regimens, and from moderately emetogenic chemotherapy, given with a 5-HT3 antagonist and dexamethasone as a three-drug regimen over three days. Preventing vomiting matters clinically as well as humanely: uncontrolled emesis causes dehydration, treatment delay, and anticipatory nausea that is very difficult to treat once established. It is a moderate CYP3A4 inhibitor, so the dexamethasone dose is reduced when given with it, and it interacts with several chemotherapy agents.

Sourcing notes. Off patent, with generic capsules widely available; fosaprepitant, the intravenous prodrug, is a separate product. Demand tracks chemotherapy volume directly and is predictable from regimen mix, which makes it a straightforward tender item.

Aprepitant — third party manufacturing & bulk supply

Aprepitant 80 mg, 125 mg capsules is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Aprepitant is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Aprepitant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Aprepitant →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Aprepitant is listed as Capsules in 80 mg, 125 mg capsules. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Aprepitant is referenced against Emend (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.